Vanberra Signal

Cypher Genomics

Curated by Signal

Providing Genome interpreting technology for clinical labs and pharmaceutical companies

Overview

Cypher Genomics genomic interpretation platform allows pharmaceutical companies to discover biomarkers from whole genome sequence data typical of early stage drug development studies & clinical laboratories to develop molecular tests for diagnostic and prognostic use. The company offers Mantis, the genome interpretation software as a service offering, and CoralTM, a biomarker discovery service.

Key facts

Founded
2011

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of analytics-driven payment accuracy solutions for healthcare payers

    Health TechnologyAtlanta, United States
  • Provides a practice management and a charting solution for dental clinics

    Health TechnologyWilmington, United States
  • Simple way for doctors to fill last minute appointment openings.

    Health TechnologySan Francisco, United States

About Cypher Genomics

What does Cypher Genomics do?

Cypher Genomics genomic interpretation platform allows pharmaceutical companies to discover biomarkers from whole genome sequence data typical of early stage drug development studies & clinical laboratories to develop molecular tests for diagnostic and prognostic use.

Where is Cypher Genomics headquartered?

Cypher Genomics is headquartered in San Diego, United States.

When was Cypher Genomics founded?

Cypher Genomics was founded in 2011.

Which sector is Cypher Genomics in?

Cypher Genomics operates in Health Technology.

Who are Cypher Genomics's competitors?

Companies similar to Cypher Genomics include Cotiviti, Dentem, and QueueDr.